Alumis’ Post

Hello from the heart of the AusBiotech 2023 conference in Brisbane! We are excited to provide you with a glimpse of the incredible insights and innovations we're experiencing right here at the forefront of biotechnology. The ambiance is charged with energy, and the excitement of knowledge sharing is truly invigorating. It's been an amazing week of connecting with brilliant minds, gaining new perspectives, and discovering the latest advancements in the life sciences field. ✨ From thought-provoking panel discussions to eye-opening keynote speeches, we've delved into groundbreaking research, emerging technologies, and the evolving challenges within our industry. The wealth of knowledge being shared is simply inspiring. 🤝 Networking here at AusBiotech is unlike any other. We've had the privilege of meeting with local and international leaders, researchers, and entrepreneurs, forging valuable connections and exploring opportunities for collaboration that will shape the future of biotechnology. 🌱 The theme of this year's conference, "Advancing Biotech - It’s in our DNA," resonates deeply. We're on the cusp of realising the vast potential that biotechnology holds for improving human life, and it's been incredible to see how each conversation and session is contributing to this journey. Akesa is proud to be a part of this remarkable event, and we're eager to continue our commitment to driving innovation and progress in the biotech industry. Together with the global biotech community, we are pushing the boundaries, nurturing innovations, and working towards solutions that can heal and feed the world. Stay tuned for more updates as we navigate through the world of biotechnology at AusBiotech 2023. The future is bright, and we're here to shape it! #AusBiotech2023 #BiotechInnovations #Letdiscoverylive #LifeSciences #Biotechnology #Innovation

These are very encouraging signs for the restoration of the threatened coral reefs of the Red Sea, one of the most beautiful underwater landscapes I've dived in.

I recently attended the Asia Bio Partnering event, which featured a diverse array of biotech firms from China, Korea, Australia, Europe, US, and other countries. Notably, the presence of Japanese biotech companies was modest, highlighting significant opportunities for these firms to enhance their engagement in Asia's vibrant biotech landscape. LYFE Capital, the early-stage lead investor in ProfoundBio, which Genmab recently acquired for USD 1.8 billion, outlined their investment preferences. They target companies that develop technologies adhering to global standards, aim for global markets, and are supported by diverse, international teams. Additionally, they announced plans to open a new office in Korea. Similarly, Johnson & Johnson's innovation hub, Jlab, is broadening its reach in Asia with established offices in Shanghai and Singapore, and plans to open a new office in Seoul. In contrast, Japan’s engagement in these initiatives remains limited. By deepening their involvement in Asia's biotech ecosystem, Japanese biotech firms could unlock new funding sources and partnership opportunities, thereby accelerating their globalization efforts and maximizing the value of their technologies. Given the instability of the Hong Kong stock market, many Chinese biotech companies are facing valuation challenges. While Nasdaq remains the most promising option, Japan could also strategically position itself as a potential IPO destination for Asian biotech firms. Informa Connect

A biotechnology revolution is taking root in rural America. Manus has established one of the largest precision fermentation facilities in the world, on the outskirts of Augusta, Georgia. This revolution is supported by the recent Biden Administration Executive Order focusing on advancing biotechnology and biomanufacturing innovation, all driving the American bioeconomy. Learn more about how the Manus biomanufacturing facility in Augusta is more than an industrial plant; it’s a beacon of transformation, a testament to the potential of advanced biotech, and a spark in an industrial rebirth in America: https://bit.ly/3sghBKV Made by Manus Bio #bioeconomy #biomanufacturing #biotechnology #WhiteHouse #syntheticbiology

𝗘𝘅𝗰𝗶𝘁𝗶𝗻𝗴 𝗡𝗲𝘄𝘀! Blue Bio Value will be at OCEANOVATION 🌊 on the panel "Unlocking the Potential: Blue Biotechnology and Its Applications." Prominent figures from the Blue Bio Value chain will delve into the transformative power of blue #biotechnology, sharing their expertise on the latest trends, challenges, and opportunities in this innovative field. The speakers include Elisabete da Costa from BlueBio Alliance, Carlos Esteban from Faber Capital, Alessandro Romano from Ittinsect - Feed for the Ocean, a Blue Bio Value alumni, and will be moderated by Marta Costa from maze impact. 𝗞𝗲𝘆 𝗱𝗶𝘀𝗰𝘂𝘀𝘀𝗶𝗼𝗻 𝗽𝗼𝗶𝗻𝘁𝘀: 🌐 Current market trends and growth areas in the blue biotechnology ecosystem 🤝 Strategies for fostering collaboration and driving innovation 🌍 Navigating industry challenges and regulatory landscapes 💡 Insights into attracting investment and shaping the future of blue biotechnology This panel promises to offer invaluable insights and actionable advice for anyone interested in the future of blue biotechnology. Don't miss out on this opportunity to learn from the best in the industry! See you there! 👋👋 Oceano Azul Foundation

A biotechnology revolution is taking root in rural America. Manus has established one of the largest precision fermentation facilities in the world, on the outskirts of Augusta, Georgia. This revolution is supported by the recent Biden Administration Executive Order focusing on advancing biotechnology and biomanufacturing innovation, all driving the American bioeconomy. Learn more about how the Manus biomanufacturing facility in Augusta is more than an industrial plant; it’s a beacon of transformation, a testament to the potential of advanced biotech, and a spark in an industrial rebirth in America: https://lnkd.in/gQcp2M9r Made by Manus. #bioeconomy #biomanufacturing #biotechnology #WhiteHouse #syntheticbiology

Today is Blue Monday but let’s look at it a little differently! What does it mean to Brandon Bioscience to be blue? 🔵 The ocean holds incredible potential for sustainable innovation. Blue-bioeconomy companies are unlocking the power of marine resources to drive sustainable economic growth. As a marine biotechnology company, we’re proud to play our part in shaping a more sustainable future. We’re also a proud members of Marine Ireland Industry Network (MIIN) and Circular Bioeconomy Cluster South-West which brings together blue-bioeconomy companies throughout Ireland to share, collaborate and continuously innovate. https://lnkd.in/egUiSRgp #BlueMonday #SustainableAgriculture

Every year, the Novo Nordisk Foundation reports on progress in research advancements, inventions, and patient treatment. The impact report serves as a testament to the Foundation's commitment to making a significant scienfic and broader societal impact on public health, sustainable development and the condition of the planet. One of the analyses in the report investigates the research the funded and how it underpins development of technology. For the first time, we see Industrial Biotechnology as one of the most common areas of research and Climate Change Mitigation Technology as one of the most common patent technology classifications highlighting - an early indication of the Foundation's shift in strategy to also focus on the sustainability of the planet. Read the report here: https://lnkd.in/dbRdkU5K The team behind the report is the Impact Area: Thomas Alslev Christensen, Henrik Barslund Fosse, Gert V. Balling, Rikke Christensen, Joan Bentzen, Rasmus Lund Jensen, Daryl Paul, Sandra Schluttenhofer, Emil Søndergaard Hansen, Anders Agerbæk Kjøller Nielsen, Kristian Raudal, Jens Christian Petersen.

In case you missed it over the bank holiday weekend - check out the #BioIntegrates2024 summary blog post featuring all of the highlights and insights from the event!

I was impressed by the organisation and the line-up of speakers at the European Forum for Industrial Biotechnology in Rotterdam this week. The final EFIB Rotterdam Statement 2023, soon to be published, was written by Claire Skentelbery, Director General of EuropaBio - the European Association for Bioindustries. The statement that was circulated at EFIB mentions many pressing issues that biotech faces in the global technology race. We were all encouraged to share the #news of this topic which is fundamental to society. The main points in the statement cover: 🧩 The EU commitment to #biotechnology support ahead of European #elections in 2024. 🧩 The 2023 announcement of the #STEP (Strategic Technologies for Europe Platform) which puts biotech in a "greater point of recognition". 🧩 #Regulation that supports biotech #investment. 🧩 Biotech has a massive potential for #decarbonisation initiatives. 🧩 #Education and awareness of biotech - not many people know about the massive potential it has to change our world and our daily lives. “Industrial biotechnology uses #enzymes, #micro-organisms and living #cells to make #biobased products from #renewable #raw materials. This is a key enabler of the EU’s transition from a #fossil-based #economy to a #green and competitive #bioeconomy in multiple sectors, including #chemicals, #pharmaceuticals, #food and #feed, #fragrances, #detergents, #paper and #pulp, #textiles and #bioenergy,” the statement said. RTDS Group SUSFERT project, funded by the Circular Bio-based Europe Joint Undertaking (CBE JU) under Horizon 2020 funding, attended the event with BIOVEXO Project - Biopesticides to fight Xylella. The news story below gives a view into the event from SUSFERT's partners: Martin Kavšček, ACIES BIO Ltd., Rüdiger Weichesmüller, AGRANA Starch and Markus Omann, Agrana Research and Innovation Center. Other people interviewed and included because they work hard to make an #impact were - Nicoló Giacomuzzi-Moore, Nelo Emerencia, Virginia Puzzolo and Albert Sánchez Carmona, Jeroen Hofenk, SwiftPharma, and Hans Ole Klingenberg, from Novozymes. https://lnkd.in/dMhq9iS5 Jonathan Clark Tristan Bath Ana Babic Ben Leitner David Donnerer Mikael Muegge Stephen Webb Juliane Seika Julia Loder Rolf Wüstenhagen